Ivermectin, Hydroxychloroquine Use Soared During COVID-19 Pandemic, Study Says

Nearly 3 million prescriptions for the two drugs were written even though the FDA had said that neither drug is approved to treat COVID-19.

Pill bottles on a pharmacy shelf. Carl DMaster/Epoch Times

Ivermectin and hydroxychloroquine prescriptions “soared far above” levels before the COVID-19 pandemic, according to a new study.

Researchers from the University of California - Los Angeles (UCLA) and other institutions said that nearly 3 million ivermectin and hydroxychloroquine prescriptions were issued during the pandemic, totaling some $272 million, according to a news release issued on Feb. 20.